Tirzepatide is an approved, extensively studied dual agonist with a proven safety record, commercial availability, and the most comprehensive Phase 3 dataset in the GLP-1 class
Tirzepatide Dosage Chart: A Quick Guide Key Takeaways Tirzepatide (the active ingredient in Zepbound and Mounjaro ) is a once-weekly injection thats FDA-approved for weight management and type 2 diabetes
86 Fracture risk A large French cohort study involving 14 253 VSG patients reported an overall major osteoporotic fracture incidence of 1.70 per 1 000 person-years, with specific rates for distal forearm/wrist (0.82), proximal humerus (0.37), clinical vertebral (0.29), and hip fractures (0.22)
Starting at $169/mo Physician monitored Physician guided Ongoing, adjusted over time Physician determined subcutaneous injection Medication, clinician, follow-ups What you can expect TWO PATHWAYS
With the tirzepatide dosing for weight loss weve discussed above, meaningful weight loss often begins within the first 4 to 8 weeks, although individual results vary depending on medication adherence, nutrition, physical activity, sleep, and underlying medical conditions
